Cargando…

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries

BACKGROUND: So far, no detailed study of the Iranian pharmaceutical market has been conducted, and only a few studies have analyzed medicine consumption and expenditure in Iran. Pharmaceutical market trend analysis remains one of the most useful instruments to evaluate the pharmaceutical systems eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kebriaeezadeh, Abbas, Koopaei, Nasser Nassiri, Abdollahiasl, Akbar, Nikfar, Shekoufeh, Mohamadi, Nafiseh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718624/ https://www.ncbi.nlm.nih.gov/pubmed/23805853 http://dx.doi.org/10.1186/2008-2231-21-52

Ejemplares similares

A model for developing a decision support system to simulate national drug policy indicators
por: Abdollahiasl, Akbar, et al.
Publicado: (2011)

Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions
por: Nassiri-Koopaei, Nasser, et al.
Publicado: (2014)

The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016
por: Zartab, Saman, et al.
Publicado: (2020)

A system dynamics model for national drug policy
por: Abdollahiasl, Akbar, et al.
Publicado: (2014)

Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children
por: Gharibnaseri, Zahra, et al.
Publicado: (2012)

Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran
por: Ashrafi Shahmirzadi, Nikinaz, et al.
Publicado: (2021)

Pharmaceutical supply chain risks: a systematic review
por: Jaberidoost, Mona, et al.
Publicado: (2013)

Trend Analysis of Medicine Consumption Based on Therapeutic Categories in Iran: 2000–2016
por: Yektadoost, Alireza, et al.
Publicado: (2018)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
por: Nikfar, Shekoufeh, et al.
Publicado: (2005)

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions
por: Abdollahias, Akbar, et al.
Publicado: (2011)

Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran
por: Aajami, Zahra, et al.
Publicado: (2019)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014)

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
por: Olyaaeemanesh, Alireza, et al.
Publicado: (2021)

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
por: Rezvanfar, Mohammad Ali, et al.
Publicado: (2013)

Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods
por: Tahmasebi, Nima, et al.
Publicado: (2015)

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

Health risks associated with the pharmaceuticals in wastewater
por: Nassiri Koopaei, Nasser, et al.
Publicado: (2017)

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
por: Keshavarz, Khosro, et al.
Publicado: (2012)

Trends in Iran Pharmaceutical Market
por: Cheraghali, Abdol Majid
Publicado: (2017)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012)

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran
por: Teimouri, Fatemeh, et al.
Publicado: (2017)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

Synthesis and Analgesic Activity of Novel Hydrazide and Hydrazine Derivatives
por: Nassiri Koopaei, Mansur, et al.
Publicado: (2013)

A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
por: Goudarzi, Zahra, et al.
Publicado: (2021)

Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective
por: Ahmadiani, Saeed, et al.
Publicado: (2016)

Despite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016
por: Zartab, Saman, et al.
Publicado: (2019)

Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study
por: Delpasand, Mansoor, et al.
Publicado: (2021)

Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran
por: Keshavarz, Khosro, et al.
Publicado: (2015)

Consistent defined threshold and equity in health
por: Nikfar, Shekoufeh, et al.
Publicado: (2015)

Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country
por: Ayati, Nayyereh, et al.
Publicado: (2021)

Correction to: Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study
por: Delpasand, Mansoor, et al.
Publicado: (2021)

Short and long term impacts of COVID-19 on the pharmaceutical sector
por: Ayati, Nayyereh, et al.
Publicado: (2020)

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience
por: Keshavarz, Khosro, et al.
Publicado: (2013)

Pharmaceutical laws and regulations in Iran: An overview
por: Zaboli, Pardis, et al.
Publicado: (2016)

Optimization of rPDT fusion protein expression by Escherichia coli in pilot scale fermentation: a statistical experimental design approach
por: Koopaei, Nasser Nassiri, et al.
Publicado: (2018)

Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

A review on inputs and outputs in determining the efficiency of universities of medical sciences by data envelopment analysis method
por: Mojahedian, Mohammad M., et al.
Publicado: (2020)

A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological Medicines
por: Zartab, Saman, et al.
Publicado: (2021)

Opportunities and obstacles to the development of nanopharmaceuticals for human use
por: Nassiri Koopaei, Nasser, et al.
Publicado: (2016)

Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use
por: Koopaei, Nasser Nassiri, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gqclk4ejiq5ifs7mu3k3at7q2s